Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03618290 · ClinicalTrials.gov registry record
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke
A clinical trial of Stroke, Acute, sponsored by Sanford Health.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT03618290: Completed study of Stroke, Acute, sponsored by Sanford Health.
NCT03618290 is a study of Stroke, Acute that has completed, run by Sanford Health. The registered enrollment target is 102 participants, below the 626-participant average among 25 other Stroke, Acute trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03618290, a study of Stroke, Acute, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to use plasma free fatty acid profiling as a biomarker for ischemic stroke. The plasma free acid profile will be specifically and significantly changed in early stages upon stroke onset, and correlate with the stroke volume and progression determined by imaging techniques.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Analyze plasma free fatty acid in blood
Study Locations (1)
North Dakota
- Sanford Health - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2018-09-19 |
| Est. Completion | 2020-01-07 |
What the finished NCT03618290 record still lists
NCT03618290 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 626-participant average among 25 other Stroke, Acute trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which Analyze plasma free fatty acid in blood is the first listed.
NCT03618290 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT03618290 about?
NCT03618290 is a clinical study titled "Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke". The purpose of the research is to use plasma free fatty acid profiling as a biomarker for ischemic stroke. The plasma free acid profile will be specifically and significantly changed in early stages upon stroke onset, and correlate with the stroke volume and progression determined by imaging techniq...
What is the current status of trial NCT03618290?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2018-09-19. Estimated completion is 2020-01-07.
What conditions does trial NCT03618290 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT03618290?
The interventions under investigation include: Analyze plasma free fatty acid in blood (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03618290?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03618290 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03618290's enrollment target sits among peer trials
102 17th of 25 higher than 9 of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
RECRUITING
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
RECRUITING
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI